For example, in the pmel-1 T cell receptor transgenic mouse model of adoptive T cell transfer, the exogenous administration of both IL-15 and IL-2 improved the anti-tumor response during the 34 days of follow-up [43]. This evidence concerns the gene IL2 and neoplasm.